Skip To Main Content
This website is intended exclusively for healthcare professionals residing and/or working in the KSA.
Campus
Campus

ATTD 2021: Technology Supporting Initiation, Titration, and Intensification

Technology has significantly improved insulin therapy management in recent years, providing solutions for unmet needs and enhancing patient care. The integration of digital solutions and new technologies has resulted in continuous glucose monitoring with alerts and alarms, improving patient adherence and persistence, leading to better long-term health outcomes. Watch the video to learn more about the key thought leader interview with Dr. Halperin, following the ATTD 2021 Congress, covering the topic: Unmet needs in people with diabetes: technology supporting initiation, titration, and intensification.

Related articles
Advancing Therapy with iGlarLixi: Differentiation from complex insulin regimens

Advancing Therapy with iGlarLixi: Differentiation from complex insulin regimens

An educational video outlining key data from indirect comparisons of iGlarLixi versus IDegAsp.

Read article
Advancing Therapy with iGlarLixi: Differentiation from other complex regimens

Advancing Therapy with iGlarLixi: Differentiation from other complex regimens

Read article
Treatment simplification of complex insulin regimens in T2D

Treatment simplification of complex insulin regimens in T2D

An educational video to discuss the challenges associated with commonly-used insulin advancement options and the need for treatment simplification for many adults with T2D. The video reviews data supporting the use of BI + GLP-1 RA FRCs versus commonly-used insulin regimens in adults with T2D.

Read article
MAT-BH-2400493/v1/Aug 2024